304 related articles for article (PubMed ID: 18521629)
1. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
2. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
van der Heijden L; van de Sande MA; Dijkstra PD
Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
[TBL] [Abstract][Full Text] [Related]
5. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
6. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
7. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
8. Does the use of polymethyl-methacrylate cement after intralesional curettage of giant cell tumors of appendicular bone guarantee reduced local recurrence rates? A retrospective analysis.
Colding-Rasmussen T; Horstmann PF; Jørgensen PH; Hettwer W; Hansen BH; Tierp-Wong CNE; Petersen MM
J Orthop Surg (Hong Kong); 2023; 31(3):10225536231202155. PubMed ID: 37688488
[TBL] [Abstract][Full Text] [Related]
9. Recurrent giant cell tumor of long bones: analysis of surgical management.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Apr; 469(4):1181-7. PubMed ID: 20857250
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stages 2 and 3 giant-cell tumor.
Labs K; Perka C; Schmidt RG
Arch Orthop Trauma Surg; 2001; 121(1-2):83-6. PubMed ID: 11195127
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
Scoccianti G; Totti F; Scorianz M; Baldi G; Roselli G; Beltrami G; Franchi A; Capanna R; Campanacci DA
Clin Orthop Relat Res; 2018 Sep; 476(9):1783-1790. PubMed ID: 30778015
[TBL] [Abstract][Full Text] [Related]
13. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
14. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
15. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
[TBL] [Abstract][Full Text] [Related]
16. Giant cell tumor of bone: treatment and outcome of 214 cases.
Balke M; Schremper L; Gebert C; Ahrens H; Streitbuerger A; Koehler G; Hardes J; Gosheger G
J Cancer Res Clin Oncol; 2008 Sep; 134(9):969-78. PubMed ID: 18322700
[TBL] [Abstract][Full Text] [Related]
17. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
[TBL] [Abstract][Full Text] [Related]
19. The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.
Wan R; Zhang W; Xu J; Hao P; Yang Y; Shen Y; Ding X; Qiu S
J Orthop Sci; 2012 Jul; 17(4):464-9. PubMed ID: 22526715
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcome of giant cell tumors of the pelvis.
Balke M; Streitbuerger A; Budny T; Henrichs M; Gosheger G; Hardes J
Acta Orthop; 2009 Oct; 80(5):590-6. PubMed ID: 19916695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
